BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Oct 18, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

T Lymphoseek tilmanocept regulatory update

Neoprobe will delay its NDA submission for Lymphoseek to perform intraoperative lymph node mapping until next half from the end of October after FDA requested the biotech include data...

Read the full 121 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >